Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Cudkowicz

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Annals of Neurology|September 2, 2022
Antibody Response to HML-2 May Be Protective in Amyotrophic Lateral SclerosisMarta Garcia-Montojo, Elena Rita Simula, Saeed Fathi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral SclerosisJason R Thonhoff, James D Berry, Eric A Macklin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 2, 2017
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosisLora L Clawson, Merit Cudkowicz, Lisa Krivickas, et al.
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Muscle & Nerve|January 4, 2020
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALSNamita A Goyal, James D Berry, Anthony Windebank, et al.
Frontiers in Neurology|December 21, 2020
Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in PatientsOvidiu C Andronesi, Katharine Nicholson, Kourosh Jafari-Khouzani, et al.
Annals of Neurology|May 28, 2023
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral SclerosisMelanie Quintana, Benjamin R Saville, Matteo Vestrucci, et al.
JAMA Neurology|March 16, 2026
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical TrialMerit Cudkowicz, Vivian E Drory, Adriano Chio, et al.
Journal of Neurology|February 17, 2024
Artificial intelligence in neurology: opportunities, challenges, and policy implicationsSebastian Voigtlaender, Johannes Pawelczyk, Mario Geiger, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Annals of Neurology|September 2, 2022
Antibody Response to HML-2 May Be Protective in Amyotrophic Lateral SclerosisMarta Garcia-Montojo, Elena Rita Simula, Saeed Fathi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 29, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral SclerosisJason R Thonhoff, James D Berry, Eric A Macklin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 2, 2017
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosisLora L Clawson, Merit Cudkowicz, Lisa Krivickas, et al.
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Muscle & Nerve|January 4, 2020
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALSNamita A Goyal, James D Berry, Anthony Windebank, et al.
Frontiers in Neurology|December 21, 2020
Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in PatientsOvidiu C Andronesi, Katharine Nicholson, Kourosh Jafari-Khouzani, et al.
Annals of Neurology|May 28, 2023
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral SclerosisMelanie Quintana, Benjamin R Saville, Matteo Vestrucci, et al.
JAMA Neurology|March 16, 2026
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical TrialMerit Cudkowicz, Vivian E Drory, Adriano Chio, et al.
Journal of Neurology|February 17, 2024
Artificial intelligence in neurology: opportunities, challenges, and policy implicationsSebastian Voigtlaender, Johannes Pawelczyk, Mario Geiger, et al.
Pageof 12